San Francisco, September, 2015Successful Acquisition of Medical Device Intellectual Property/Patents by Gerbsman Partners for a Coronary Vascular Medical Device Company
Steven R. Gerbsman, Principal of Gerbsman Partners, announced today his success in acquiring Intellectual Property/Patents in vascular technology for a coronary/vascular medical device company. The IP/Patents focus on an external support device for saphenous veins that is used as bypass conduits in coronary artery bypass grafting (CABG) surgery.

Gerbsman Partners provided Financial and Strategic Advisory leadership to its Client, facilitated the sale of the Intellectual Property/Patents and closing of the sale. Due to market conditions, Gerbsman Partners Client made the strategic decision to seek to acquire certain Intellectual Property/Patents. Gerbsman Partners provided leadership to the company with:

Business Consulting and Investment Banking domain expertise in developing the strategic action plans for the strategy to acquire Intellectual Property/ Patents;

The ability to “Manage the Process” among Acquirers, Seller, Lawyers, and Management;

Communications with the Client’s Board of Directors, senior management, sthe seller and parties in interest.

About Gerbsman Partners

Gerbsman Partners focuses on maximizing enterprise value for stakeholders and shareholders in under-performing, under-capitalized and under-valued companies and their Intellectual Property. Since 2001, Gerbsman Partners has been involved in maximizing value for 91 Technology, Medical Device, Life Science, Solar, Fuel Cell, Cyber/Data Security and Digital Marketing companies and their Intellectual Property and has restructured/terminated over $810 million of real estate executory contracts and equipment lease/sub-debt obligations. Since inception in 1980, Gerbsman Partners has been involved in over $2.3 billion of financings, restructurings and M&A transactions.

Gerbsman Partners has offices and strategic alliances in San Francisco, Boston, New York, Washington, DC, McLean, VA, Europe and Israel.